PDCD1LG2 and melanoma: We conclude that in contrast to PD-L2 protein expression, PD-L2 methylation allows to determine not only the effective expression status of melanoma cells, but also the ability to express PD-L2 under proinflammatory conditions, i.e., in the presence of IFN-γ.